CLINICAL_TRIALS ClinicalTrials.gov record update

Phase 2 Trial to Investigate the Clinical Efficacy & the Optimal Administration (Based on the Immunological, Clinical & Neuroradiological Effects) of Autologous Mesenchymal Bone Marrow Stem Cells in Active & Progressive Multiple Sclerosis

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT02166021
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:37:12.950647+00:00
Published At: 2019-08-01T00:00:00+00:00
Record Updated At: 2019-08-01
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Multiple Sclerosis (MS)"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2019-08-01"
protocolSection.identificationModule.nctId: "NCT02166021"
protocolSection.identificationModule.officialTitle: "Phase 2 Trial to Investigate the Clinical Efficacy \u0026 the Optimal Administration (Based on the Immunological, Clinical \u0026 Neuroradiological Effects) of Autologous Mesenchymal Bone Marrow Stem Cells in Active \u0026 Progressive Multiple Sclerosis"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.